Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. VP Pharmacy Partners LLC
WARNING LETTER
•VP Pharmacy Partners LLC•February 3, 2015

VP Pharmacy Partners LLC – FDA Warning Letter, Feb 3, 2015

Record Details

On December 18, 2015, the FDA issued a Warning Letter to Spoonamore Drug Co. Inc., dba Louisville Pharmacy and Custom Script, following an inspection from January 13 to February 3, 2015. The inspection revealed the firm was producing drug products without valid prescriptions for individually-identified patients and had serious deficiencies in sterile drug production, posing contamination risks.

Key violations include: 1. **Compounded Drugs:** The firm did not receive valid prescriptions for individually-identified patients for a portion of its drug products, thus not qualifying for exemptions under FDCA Section 503A. Domperidone products, which are not eligible for 503A exemptions, were also produced. 2. **Unapproved New Drugs:** Drugs compounded without individual prescriptions lacked FDA approval, violating FDCA Sections 505(a) and 301(d). 3. **Misbranded Drugs:** Products compounded without individual prescriptions were misbranded under FDCA Section 502(f)(1) because they lacked adequate directions for layperson use. 4. **Adulterated Drug Products:** Sterile drug products were prepared under insanitary conditions, violating FDCA Section 501(a)(2)(A). Specific issues included not using a sporicidal agent in the cleanroom/ISO 5 area and failing to monitor pressure differential between ISO 7 and ISO 8 areas. 5

Company
VP Pharmacy Partners LLC
Inspection date
February 3, 2015
Product type
Drugs
Office
Cincinnati District Office
People
  • Steven Barber (District Director at FDA)
  • Rupa Murthy
  • Steven Hart (B.)
View Company Profile

ID · 4964be5c-9a4e-44b9-9f3b-bd4e3c4a766e

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 U.S.C. 353a21 U.S.C. 351(a)(2)(A)21 U.S.C. 352(f)(1)21 U.S.C. 35521 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 331(k)21 CFR 211.42(c)(10)(iv)21 CFR 211.42(c)(10)(v)

Full citation text and observation details available on the Dashboard.

Other documents for VP Pharmacy Partners LLC
  • 483 - 2017-03-14March 14, 2017
  • STATE_REFERRAL_LETTER - 2017-01-17January 17, 2017
  • 483 - 2015-02-03February 3, 2015

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore VP Pharmacy Partners LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.